Remarkably, while most publications have focused on downstream targets beyond SPARC and the cellular functions of SPARC itself, much less is known about the mechanisms by which this gene is aberrantly expressed in cancers, particularly in melanoma. The gene discussed is SPARC; the disease is cancer.